Loading stock data…
LFVN
$9.52-1.18 (-11.03%)
Market OpenUpdated 3:57 PM EDT
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
LifeVantage Corporation in the Consumer Defensive sector is trading at $9.52. Wall Street consensus targets $7.00 (2 analysts), implying a -26.5% move over the next 12 months. The stock is currently 37% below its 52-week high of $15.00, remaining 39.8% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -26.5% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$9.52
Potential Downside
0%
Whystock Fair Value$9.52
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internati...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.58%
ROE
Elite ROE. Management converts capital into profit efficiently.
17.25%
Volume
Today's trading volume
896,543
Recent News
LifeVantage Corporation (NASDAQ:LFVN) Pays A US$0.05 Dividend In Just Three Days
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Do Options Traders Know Something About LifeVantage Stock We Don't?
Investors need to pay close attention to LFVN stock based on the movements in the options market lately.
Lake Street Capital Markets Downgrades LifeVantage Corporation (LFVN) After Weak Q3 Results
LifeVantage Corporation (NASDAQ:LFVN) is included among the 12 Best Micro-Cap Dividend Stocks to Buy Now. On May 7, Lake Street downgraded LifeVantage Corporation (NASDAQ:LFVN) to Hold from Buy and set a $5 price target after the company reported weaker-than-expected Q3 results. The analyst said management kept its prior FY26 guidance framework in place but now expects […]
Lifevantage Q3 Earnings Call Highlights
Lifevantage (NASDAQ:LFVN) reported fiscal third-quarter 2026 results that reflected a sharp year-over-year revenue decline, as management pointed to weaker demand for its MindBody GLP-1 System and fewer active accounts. On the call, the company also highlighted a leadership transition, ongoing techn
LifeVantage Corporation Q3 2026 Earnings Call Summary
Moby summary of LifeVantage Corporation's Q3 2026 earnings call